Artemis Medicare Services Share Price
Small Cap | Pharmaceuticals and health care | NSE: ARTEMISMED | BSE: 542919
₹270.15 
-4.50 (-1.64 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 275.75
High (₹) 278.80
Low (₹) 266.70
Prev. Close (₹) 274.65
Volume 6,398
VWAP (₹) 270.50
ROCE (%) 12.67
Industry P/E 90.16
TTM P/E 50.40
P/B Ratio 9.44
Market Cap (₹) Cr.3,698.06
Dividend Yield (%)0.17
EPS (₹) 3.53
ROE12.40%
Sales Growth (%) 19.14
Profit Growth (%)29.29
Day Range
278.80278.80
52 Week Range
140.60348.30
Historical Returns
Returns (6M)
-0.55 %
Returns (1Y)
46.46 %
Returns (3Y)
538.65 %
Returns (5Y)
1100.67 %
Returns (6M)
-0.55 %
Returns (1Y)
46.46 %
Returns (3Y)
538.65 %
Returns (5Y)
1100.67 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (26.52%) TTM EPS Growth
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 26.52% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
Technicals
Technical Rating
BEARISHRSI 42.84
MFI 25.69
ATR 17.24
Commodity Channel Index -48.61
ROC125 -2.76
ROC21 -10.45
Williams %R -71.91
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 276.44 | 283.67 | 288.54 | 271.57 | 264.34 | 259.47 | 252.24 |
| Week Ago | 273.60 | 285.60 | 294.40 | 264.80 | 252.80 | 244.00 | 232.00 |
| Month Ago | 318.60 | 328.80 | 338.10 | 309.30 | 299.10 | 289.80 | 279.60 |
EMA & SMA
270.15
Current Price
Bullish Moving Averages
8
Bearish Moving Averages
12
5 Day 264.23
9 Day 266.01
10 Day 267.89
12 Day 275.68
14 Day 281.21
20 Day 285.94
26 Day 291.41
50 Day 305.66
100 Day 298.11
200 Day 260.85
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 22 Jun, 2021 | Neeru Wahal | Acquisition | ₹301.5179768433881779402803169 | 1,641 | BSE |
| 22 Jun, 2021 | Prem Narain Wahal | Acquisition | ₹301.7157024793388429752066116 | 605 | BSE |
| 22 Jun, 2021 | Neeru Wahal | Acquisition | ₹300.8079470198675496688741722 | 1,359 | BSE |
| 22 Jun, 2021 | Prem Narain Wahal | Acquisition | ₹300.6995230524642289348171701 | 2,516 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 10 May, 2024 | Rs.0.4500 per share(45%)Final Dividend | 05 Jul, 2024 | 05 Jul, 2024 |
| 05 May, 2023 | Rs.0.4500 per share(45%)Dividend | 14 Jul, 2023 | 14 Jul, 2023 |
| 05 Aug, 2021 | Stock split from Rs. 10/- to Re. 1/-. | 23 Sept, 2021 | 24 Sept, 2021 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 17 Feb, 2025 | NSE India | Artemis Medicare Services Limited has informed the Exchange regarding ''Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015''. |
| 06 Feb, 2025 | NSE India | Artemis Medicare Services Limited has informed the Exchange about Newspaper Publication-February 6, 2025 |
| 05 Feb, 2025 | NSE India | Monitoring Agency Report for the quarter ended December 31, 2024 |
| 05 Feb, 2025 | BSE India | Monitoring Agency Report for the quarter ended December 31, 2024 |
| 05 Feb, 2025 | NSE India | Artemis Medicare Services Limited has informed the Exchange about Investor Presentation |
| 05 Feb, 2025 | BSE India | Earnings Presentation-Q3 and 9M FY2025 |
| 05 Feb, 2025 | NSE India | Artemis Medicare Services Limited has informed the Exchange regarding a press release dated February 05, 2025, titled ""Artemis Consolidates its Performance with YoY Growth in Financial and Operational Metrics, Reporting Highest ever ARPOB, Continued Focus on Tower 3 Ramp up and Expansion Strategy"". |
| 05 Feb, 2025 | BSE India | Press Release-February 5, 2025 |
| 05 Feb, 2025 | NSE India | Intimation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
| 05 Feb, 2025 | BSE India | Intimation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 31 Jan, 2025 | 05 Feb, 2025 |
| Quarterly Results | -- | 07 Nov, 2024 | 14 Nov, 2024 |
| Quarterly Results | -- | 02 Aug, 2024 | 08 Aug, 2024 |
| Audited Results & Final Dividend | -- | 07 May, 2024 | 10 May, 2024 |
| Others | Inter alia, to consider : (1) the proposal for raising of funds by way of means permissible under applicable laws such as issue of equity shares/ convertible bonds/debentures/ warrants. | 03 Apr, 2024 | 05 Apr, 2024 |
| Quarterly Results | -- | 30 Jan, 2024 | 05 Feb, 2024 |
| Quarterly Results | -- | 02 Nov, 2023 | 08 Nov, 2023 |
| Quarterly Results | -- | 02 Aug, 2023 | 08 Aug, 2023 |
| Audited Results & Dividend | -- | 02 May, 2023 | 05 May, 2023 |
| Quarterly Results | -- | 26 Jan, 2023 | 01 Feb, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Artemis Medicare Services
Artemis Medicare Services is a Public Limited Listed company incorporated on 18/05/2004 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L85110DL2004PLC126414 and registration number is 126414. Currently Company is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 845.23 Cr. and Equity Capital is Rs. 13.59 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Raunaq Group
Founded
2004
Managing Director
Dr.(Mrs.) Devlina Chakravarty
NSE Symbol
ARTEMISMED
Artemis Medicare Services Management
| Name | Designation |
|---|---|
| Mr. Onkar Kanwar | Chairman & Non-Exe.Director |
| Dr.(Mrs.) Devlina Chakravarty | Managing Director |
| Mr. Neeraj Kanwar | Non Executive Director |
| Dr. Nirmal Kumar Ganguly | Non Executive Director |
| Mrs. Shalini Kanwar Chand | Non Executive Director |
| Dr. Sanjaya Baru | Independent Director |
| Ms. Deepa Gopalan Wadhwa | Independent Director |
| Mr. Sunil Tandon | Independent Director |
| Mr. Sanjib Sen | Independent Director |
| Dr. Subbaraman Narayan | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Max Heal.Ins | ₹1,09,500.95 | ₹1,010.25  ₹1,031.85(-2.09%) | ₹669.650 - ₹1,215.000 |
| Apollo Hspt | ₹1,04,190.68 | ₹6,317.55 ₹6,390.95(-1.15%) | ₹5,639.700 - ₹7,545.100 |
| Fortis Healt | ₹51,495.70 | ₹619.35  ₹609.90(1.55%) | ₹375.100 - ₹740.100 |
| GlobalHealth | ₹29,286.77 | ₹1,235.55 ₹1,206.40(2.42%) | ₹930.000 - ₹1,513.750 |
| Narayana Hru | ₹26,515.81 | ₹1,396.80 ₹1,404.55(-0.55%) | ₹1,087.800 - ₹1,445.050 |
FAQs on Artemis Medicare Services
What is the share price of Artemis Medicare Services?
The share price of Artemis Medicare Services on 21 Feb, 2025 is ₹ 270.15.
What is 52W high and 52W low share price of Artemis Medicare Services?
The highest and lowest 52W share prices of Artemis Medicare Services are ₹ 348.300 and ₹ 140.600
What is the market cap of Artemis Medicare Services?
The market capitalization of Artemis Medicare Services as of 21 Feb, 2025 is ₹ 3,698.06 Crores
What is the P/E ratio of Artemis Medicare Services?
The current P/E ratio of Artemis Medicare Services as of 21 Feb, 2025 is 90.16
What is the PB ratio of Artemis Medicare Services?
The PB ratio of Artemis Medicare Services as of 21 Feb, 2025 is 9.44
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)